Federal regulators fast-tracked approval of psychedelic drugs to treat some of the nation’s most stubborn mental health disorders, reopening a debate that has lingered since the counterculture era: ...

Are psychedelics the next big thing?Psychedelics include the drugs LSD, magic mushrooms, peyote, and often ketamine and MDMA ...

In a world gripped by a growing mental health crisis, research suggests that psychedelic-assisted therapy could be an answer.

After an executive order, the FDA announced it would prioritize the study of some psychedelic drugs for therapeutic use. Which did they choose and why?

Yet this area of medicine also demands extra care — or the U.S. risks unleashing complex therapies into an infrastructure unprepared to support them. Americans have already seen what happens when a ...

The Lancet published an Editorial on reviving research into psychedelics for mental health conditions, observing that “the ...

Psychedelics are having a moment — in labs, in legislatures and in mental health spaces. But how does the U.S. public ...

The president will direct federal agencies to boost research into the drugs and support clinical trials, moves championed by Health Secretary Robert F. Kennedy Jr.

Trump’s orders move the U.S. a few steps closer to more widespread research on and use of two sets of controversial yet promising drugs, psychedelic and cannabis products ...

The White House directive to put psychedelics on a regulatory fast track is welcome, and worrisome. This area of medicine demands extra care, or the U.S. risks unleashing complex therapies into an ...